Cover Image
市場調查報告書

吸入型氣喘治療藥市場

Inhaled Asthma Therapeutics

出版商 Greystone Research Associates 商品編碼 304993
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
吸入型氣喘治療藥市場 Inhaled Asthma Therapeutics
出版日期: 2014年06月04日 內容資訊: 英文
簡介

氣喘仍然是顯示高發病率和罹患率的醫療領域。主要因為受氣喘之苦的患者的人口區分為兒童和老年人,因此對容易使用的吸入器的開發有顯著的關心。新世代的口服氣喘吸入器,編入對這個配合措施相對應的功能和設計因素,實現更容易使用、安全的設備的開發,並對應提高遵守這個目標。藥物處方及吸入設備設計的發展,作為替代口服及非口服的藥物輸送手法,產生對吸入藥物輸送手法來說新的市場機會。

本報告提供吸入型氣喘治療藥市場相關分析、治療標的、處方趨勢、概括治療策略等的市場動態、吸入技術、產品開發因素、氣喘吸入器設計因素相關分析彙整、吸入型氣喘產品的市場預測、法規及標準化環境,以及主要企業簡介等彙整資料,為您概述為以下內容。

摘要整理

氣喘治療藥市場動態

  • 設備、處方及市場發展
  • 確立的治療標的
  • 處方趨勢
  • 治療策略
  • 適應症、投藥及病人依從性
  • 催促成長的因素

吸入技術與產品開發要素

  • 藥品處方和處方技術
  • 吸入設備設計因素
    • 乾燥粉末吸入器
    • 定量吸入器
    • 噴霧器
  • 投藥再現性
  • 活性化合物的穩定性
  • 新的設備技術

氣喘吸入器設計因素

  • 投藥包裝
  • 新的處方技術
  • 事前吸入技術
  • 用戶確認/回饋/疾病管理
  • 置入式電子產品
  • 組合(多劑)吸入器

吸入型氣喘產品分析、市場資料、預測

  • 皮質類固醇
  • 支氣管擴張劑
    • 短時間作用型β2刺激藥(SABA)
    • 長時間作用型β2刺激藥(LABA)
    • 抗膽鹼促效劑
  • 肥胖細胞穩定劑
  • 多劑吸入器
  • 其他重要/新興藥品級

市場要素

  • 法規和標準
  • 臨床試驗
  • 醫療經濟
  • 管理護理與醫療費負擔者倡議

企業簡介

目錄
Product Code: NHA392R

Evolving Technology Attempts to Address an Unmet Need

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment of the population of asthma sufferers are children or elderly patients. The new generation of oral asthma inhalers incorporates features and design elements that address this initiative, enabling devices that are more user-friendly and safe, and in the process support the parallel goal of improved compliance. Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods.

Highlights

  • Analyzes therapeutic drugs and pipeline candidates delivered via oral inhalers for treating asthma
  • Assesses inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
  • Provides detailed assessments of inhaled drug targeted disease segments, growth prospects and market potential
  • Provides market data and forecasts for inhaled asthma therapeutic drugs to 2020
  • Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Table of Contents

Executive Summary

Asthma Therapeutics Market Dynamics

  • Devices, Formulations and Market Evolution
  • Established Therapeutic Targets
  • Prescribing Trends
  • Therapeutic Strategies
  • Indications, Dosing and Patient Compliance
  • Factors Driving Growth

Inhalation Technology & Product Development Factors

  • Drug Formulations & Formulation Technologies
  • Inhalation Device Design Factors
    • Dry Powder Inhalers
    • Metered Dose Inhalers
    • Nebulizers
  • Dose Reproducibility
  • Active Compound Stability
  • Emerging Device Technologies

Asthma Inhaler Design Factors

  • Dose Packaging
  • Novel Formulation Technology
  • Pre-inspiry Technology
  • User Confirmation/Feedback/Disease Management
  • Embedded Electronics
  • Combination (multidrug) Inhalers

Inhaled Asthma Product Analysis, Market Data & Forecasts

  • Corticosteroids
  • Brohchodilators
    • Short-acting B2 Agonists
    • Long-acting B2 Agonists
    • Anticholinergics
  • Mast Cell Stabilizers
  • Multidrug Inhalers
  • Other Important/Emerging Drug Classes

Market Factors

  • Regulations and Standards
  • Clinical Trials
  • Healthcare Economics
  • Managed Care and Payor Initiatives

Company Profiles

Back to Top